Trial Profile
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Aug 2012
Price :
$35
*
At a glance
- Drugs Modafinil (Primary)
- Indications Narcolepsy; Somnolence
- Focus Therapeutic Use
- Sponsors Cephalon
- 28 Aug 2012 New trial record